Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2023-05-23 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
关于因权益分派调整健帆转债转股价格的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding the adjustment of the conversion price of its convertible bonds due to equity distribution (cash dividends). It details the previous and adjusted conversion prices, the calculation method, and the effective date of the adjustment. The document includes regulatory compliance statements and references to prior announcements about conversion price adjustments. It does not contain financial statements or comprehensive financial data but focuses on a specific capital structure change related to convertible bonds. This fits the category of a Capital/Financing Update (CAP), as it informs about changes in the company's capital instruments (convertible bonds) and their terms.
2023-05-23 Chinese
关于完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of a business registration change following a shareholder meeting where the company approved an increase in registered capital due to stock option exercises. It includes details about the updated company registration information and the issuance of a new business license. The document is short (1529 characters) and serves as a formal notification of the completion of the registration change, not a full financial report or detailed filing. It does not contain financial statements or detailed analysis but is a regulatory announcement about corporate registration changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-05-23 Chinese
关于奋斗者一号员工持股计划实施进展的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the progress of an employee stock ownership plan (奋斗者一号员工持股计划) implemented by the company. It provides details on the number of shares purchased through the market, the total amount spent, and the percentage of total shares. The document references prior approvals by the board and shareholders and compliance with regulatory guidelines. It is a disclosure about a share purchase plan implementation progress, not a full financial report, earnings release, or management discussion. It fits best under the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares or employee stock plans involving share purchases. The document length is short and focused on this specific transaction update, not a broader report or announcement of a report publication.
2023-05-22 Chinese
关于实施权益分派期间健帆转债暂停转股的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the suspension of conversion rights of its convertible bonds during the equity distribution period. It includes details about bond codes, suspension and resumption dates, and the formula for adjusting the conversion price. The document is a notice about a temporary change in bond conversion terms related to equity distribution, not a financial report or earnings release. It is not a full report but an announcement related to capital structure and bond conversion rights. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and it contains substantive information about financing terms, not just a report publication or regulatory filing.
2023-05-22 Chinese
关于董事收到广东证监局警示函的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a warning letter issued by the Guangdong Securities Regulatory Bureau to a company director due to insider trading violations. It details the regulatory action taken and the company's response to strengthen compliance. There is no financial data, no report attached or referenced as being published, and no mention of a meeting or voting results. The content fits best under a regulatory announcement about legal/regulatory compliance matters involving company directors. Therefore, it is classified as a Regulatory Filings (RNS) document.
2023-05-19 Chinese
关于部分募集资金专户注销完成的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of the cancellation of certain fundraising special accounts related to convertible bonds issued by the company. It details the use and management of the raised funds, approvals by the board and shareholders, and the termination of related regulatory agreements. The document does not contain financial statements or detailed financial performance data but rather informs about the administrative and regulatory status of fundraising accounts. The length is 2240 characters, which is relatively short and the content is focused on a specific corporate action related to capital management. This fits best under Capital/Financing Update (CAP) as it updates on the status of fundraising capital and related accounts.
2023-05-15 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.